Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
Al Enazi
Madallah M
MM
Kadry
Razan
R
Mitwali
Hadeel
H
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced*; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib